Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST - Nasdaq - US61174X1090 - Common Stock - Currency: USD

63.08  +0.04 (+0.06%)

After market: 62.99 -0.09 (-0.14%)

Fundamental Rating

6

Taking everything into account, MNST scores 6 out of 10 in our fundamental rating. MNST was compared to 32 industry peers in the Beverages industry. Both the health and profitability get an excellent rating, making MNST a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, MNST is valued expensive at the moment. With these ratings, MNST could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MNST was profitable.
MNST had a positive operating cash flow in the past year.
MNST had positive earnings in each of the past 5 years.
MNST had a positive operating cash flow in each of the past 5 years.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

MNST has a Return On Assets of 18.35%. This is amongst the best in the industry. MNST outperforms 96.88% of its industry peers.
MNST's Return On Equity of 23.16% is fine compared to the rest of the industry. MNST outperforms 78.13% of its industry peers.
The Return On Invested Capital of MNST (23.04%) is better than 96.88% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MNST is significantly above the industry average of 11.61%.
The last Return On Invested Capital (23.04%) for MNST is above the 3 year average (19.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROIC 23.04%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

MNST has a Profit Margin of 20.27%. This is amongst the best in the industry. MNST outperforms 90.63% of its industry peers.
MNST's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 28.00%, MNST belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Operating Margin of MNST has declined.
MNST has a Gross Margin of 54.64%. This is in the better half of the industry: MNST outperforms 68.75% of its industry peers.
MNST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28%
PM (TTM) 20.27%
GM 54.64%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MNST is creating value.
Compared to 1 year ago, MNST has less shares outstanding
The number of shares outstanding for MNST has been reduced compared to 5 years ago.
The debt/assets ratio for MNST is higher compared to a year ago.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

MNST has an Altman-Z score of 25.13. This indicates that MNST is financially healthy and has little risk of bankruptcy at the moment.
MNST's Altman-Z score of 25.13 is amongst the best of the industry. MNST outperforms 100.00% of its industry peers.
MNST has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
MNST has a better Debt to FCF ratio (0.12) than 87.50% of its industry peers.
MNST has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MNST (0.03) is better than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Altman-Z 25.13
ROIC/WACC2.56
WACC8.99%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

MNST has a Current Ratio of 3.37. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
MNST's Current ratio of 3.37 is amongst the best of the industry. MNST outperforms 81.25% of its industry peers.
MNST has a Quick Ratio of 2.78. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.78, MNST belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.78
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

MNST shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.75%.
MNST shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.72% yearly.
MNST shows a small growth in Revenue. In the last year, the Revenue has grown by 1.47%.
Measured over the past years, MNST shows a quite strong growth in Revenue. The Revenue has been growing by 12.27% on average per year.
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%

3.2 Future

The Earnings Per Share is expected to grow by 15.04% on average over the next years. This is quite good.
MNST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.05% yearly.
EPS Next Y17.7%
EPS Next 2Y14.53%
EPS Next 3Y13.01%
EPS Next 5Y15.04%
Revenue Next Year6.17%
Revenue Next 2Y7.07%
Revenue Next 3Y7%
Revenue Next 5Y8.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

MNST is valuated quite expensively with a Price/Earnings ratio of 38.00.
The rest of the industry has a similar Price/Earnings ratio as MNST.
MNST is valuated rather expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
MNST is valuated quite expensively with a Price/Forward Earnings ratio of 29.87.
The rest of the industry has a similar Price/Forward Earnings ratio as MNST.
MNST is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38
Fwd PE 29.87
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNST indicates a slightly more expensive valuation: MNST is more expensive than 62.50% of the companies listed in the same industry.
MNST's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.24
EV/EBITDA 27.57
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MNST may justify a higher PE ratio.
MNST's earnings are expected to grow with 13.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.15
PEG (5Y)N/A
EPS Next 2Y14.53%
EPS Next 3Y13.01%

0

5. Dividend

5.1 Amount

No dividends for MNST!.
Industry RankSector Rank
Dividend Yield N/A

MONSTER BEVERAGE CORP

NASDAQ:MNST (7/3/2025, 7:50:40 PM)

After market: 62.99 -0.09 (-0.14%)

63.08

+0.04 (+0.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners68.16%
Inst Owner Change0.17%
Ins Owners0.49%
Ins Owner Change6.65%
Market Cap61.52B
Analysts74.19
Price Target63.52 (0.7%)
Short Float %2.33%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.47%
Min EPS beat(2)-6.99%
Max EPS beat(2)0.06%
EPS beat(4)1
Avg EPS beat(4)-6.66%
Min EPS beat(4)-11.44%
Max EPS beat(4)0.06%
EPS beat(8)2
Avg EPS beat(8)-4.49%
EPS beat(12)3
Avg EPS beat(12)-5.41%
EPS beat(16)4
Avg EPS beat(16)-4.88%
Revenue beat(2)0
Avg Revenue beat(2)-4.61%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.98%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-3.85%
Revenue beat(12)1
Avg Revenue beat(12)-3.56%
Revenue beat(16)4
Avg Revenue beat(16)-1.96%
PT rev (1m)5.69%
PT rev (3m)11.02%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)3.76%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)2.12%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 38
Fwd PE 29.87
P/S 8.26
P/FCF 34.24
P/OCF 30.39
P/B 9.44
P/tB 16.31
EV/EBITDA 27.57
EPS(TTM)1.66
EY2.63%
EPS(NY)2.11
Fwd EY3.35%
FCF(TTM)1.84
FCFY2.92%
OCF(TTM)2.08
OCFY3.29%
SpS7.64
BVpS6.68
TBVpS3.87
PEG (NY)2.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROCE 29.78%
ROIC 23.04%
ROICexc 31.64%
ROICexgc 68.61%
OM 28%
PM (TTM) 20.27%
GM 54.64%
FCFM 24.13%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Debt/EBITDA 0.09
Cap/Depr 267.77%
Cap/Sales 3.05%
Interest Coverage 71.04
Cash Conversion 93.27%
Profit Quality 119%
Current Ratio 3.37
Quick Ratio 2.78
Altman-Z 25.13
F-Score7
WACC8.99%
ROIC/WACC2.56
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
EPS Next Y17.7%
EPS Next 2Y14.53%
EPS Next 3Y13.01%
EPS Next 5Y15.04%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%
Revenue Next Year6.17%
Revenue Next 2Y7.07%
Revenue Next 3Y7%
Revenue Next 5Y8.05%
EBIT growth 1Y3.72%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year15.46%
EBIT Next 3Y11.01%
EBIT Next 5Y11.74%
FCF growth 1Y62.57%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y54.2%
OCF growth 3Y18.61%
OCF growth 5Y11.61%